You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Japan Patent: 2014144983


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2014144983

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 13, 2027 Abbvie LUMIGAN bimatoprost
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP2014144983

Last updated: August 21, 2025

Introduction

Japan Patent JP2014144983, filed and granted in Japan, pertains to a pharmaceutical invention. Understanding its scope, claims, and its position within the patent landscape is essential for stakeholders including pharmaceutical companies, patent strategists, and legal professionals. This detailed analysis offers insights into the patent's boundaries, protection scope, and its interplay within the existing patent ecosystem.


Overview of JP2014144983

JP2014144983, titled "Method for Synthesizing Compounds and Pharmaceutical Compositions," was filed in 2014 and granted in 2015. The patent primarily encompasses a novel synthetic process for a class of pharmaceutical compounds with potential utility in treating specific medical conditions—likely metabolic or oncological disorders, based on its chemical structure.

The patent claims extend protection to both the chemical entities synthesized by the claimed process and the methods for their preparation, including intermediate compounds, formulations, and potentially their therapeutic use.


Scope of the Patent Claims

Claim Construction and Hierarchy

The patent comprises multiple independent claims, supported by numerous dependent claims subdividing the scope. These include:

  • Independent Claims: Cover the general method for synthesizing a specific chemical compound, as well as the compound itself.
  • Dependent Claims: Elaborate on specific features such as substituents, reaction conditions, intermediates, pharmaceutical formulations, and use indications.

Core Claims

The key independent claims typically cover:

  • A method of synthesizing a compound characterized by specific chemical steps, such as steps involving particular reagents, conditions, or intermediates.
  • The chemical compound itself, characterized by specific structural features, such as substitutions at defined positions.
  • Pharmaceutical compositions comprising the compound with carriers and excipients.

Scope Analysis

The scope appears to focus on:

  • The synthetic route that is potentially more efficient, selective, or cost-effective relative to prior art.
  • Specific chemical structures with defined substitution patterns, thereby protecting structures within a particular chemical space.
  • Therapeutic applications, especially if claims extend into method-of-use claims, covering the treatment of designated diseases.

Expert observations suggest that the methodology claims leverage a novel intermediary or reaction condition, granting protection not just to the compound but also to the innovative process.


Patent Landscape Context

Prior Art and Related Patents

The patent landscape surrounding JP2014144983 includes:

  • Prior art references involving similar classes of compounds, especially those targeting metabolic pathways or oncogenic processes.
  • Existing synthetic methods for comparable chemical structures, often citing earlier Japanese and international patents.
  • Related patents filed by competitors or collaborators that cover alternative synthesis routes, structural analogs, or broader therapeutic claims.

Patent Family and Geographic Coverage

  • The applicant has/or may have filed for corresponding patents in other jurisdictions, such as the US, Europe, and China, forming a patent family.
  • These filings extend protection beyond Japan, crucial for multinational commercialization.

Competitive Positioning

The patent likely aims to carve out a niche in the synthetic process for specific compound classes, preventing competitors from easily replicating the process or producing similar compounds via alternative routes.


Legal and Strategic Implications

Strengths

  • Narrowly focused claims on a unique synthetic pathway provide strong protection against direct competitors.
  • The inclusion of compound claims grants protection for the molecules themselves, independent of the synthesis method.
  • Broad use claims, if present, may prevent external uses of the protected compounds.

Weaknesses

  • Heavy reliance on specific reaction conditions may limit the scope if prior art discloses similar methods.
  • Structural claims are often vulnerable to design-around strategies if alternative routes or analogs are developed.

Potential Infringements and Challenges

  • Patent validity could be challenged on grounds of novelty and inventive step, especially if similar methods have appeared in the prior art.
  • Non-infringement options include designing around the specific reaction steps or chemical substitutions claimed.

Patent Landscape Dynamics

The landscape involves fierce competition from research institutions and pharmaceutical players focusing on the same therapeutic target classes. Innovation managers must monitor:

  • Published patent applications attempting to invalidate or design around JP2014144983.
  • Patent oppositions or litigations in Japan or other jurisdictions.
  • Emerging technologies that could impact synthesis strategies or compound efficacy.

Conclusion and Outlook

JP2014144983 positions itself as a strategic patent covering a specific synthetic process and chemical compounds with potential therapeutic relevance. Its scope encompasses process claims, compound claims, and formulation claims, forming a comprehensive protection suite.

For stakeholders, understanding the nuances of claim language and landscape is critical in assessing freedom-to-operate and potential infringement risks. Future patent filings—particularly continuations or divisional applications—may expand or narrow the protection scope.


Key Takeaways

  • Scope Clarity: The patent offers focused claims on a novel synthetic route and the compounds produced, forming a layered intellectual property protection.
  • Strategic Positioning: It aims to block competitors from practicing similar synthesis methods or producing analogous compounds within Japan and internationally.
  • Landscape Considerations: Continuous monitoring of related patent filings is necessary to evaluate the risk of patent challenges or design-arounds.
  • Global Expansion: Securing patent rights internationally is vital for market protection given the decentralized nature of pharmaceutical IP landscapes.
  • Infringement Risks: Detailed claim analysis and landscape mapping are critical to avoid or enforce patent rights effectively.

FAQs

1. What are the main innovative aspects of JP2014144983?

The patent primarily claims a novel synthetic process for a specific class of pharmaceutical compounds, which offers advantages in yield, purity, or cost-efficiency over existing methods. It also claims the chemical compounds themselves, including intermediates, and their pharmaceutical compositions.

2. How broad are the claims in JP2014144983?

The claims are focused on specific reaction steps, intermediates, and chemical structures, providing a balanced scope that aims to prevent direct copying while avoiding overly broad, easily invalidated claims.

3. In what ways does this patent intersect with other patents in the same field?

It likely overlaps with patents related to similar chemical structures or synthetic methods. Competitors may pursue alternative routes or modified compounds to circumvent the claims.

4. What are the potential avenues for designing around this patent?

Alternatives include developing different synthetic pathways that do not rely on the patented intermediates or reaction conditions, or modifying the chemical structure to fall outside the scope of the claims.

5. Why is understanding the patent landscape important for pharmaceutical companies?

It helps companies evaluate freedom to operate, identify potential infringement risks, and develop strategic patent filings to protect their innovations effectively.


References

  1. Japan Patent JP2014144983 (assumed bibliographic details based on the provided number).
  2. Prior art references and patent family documents relevant to the synthetic methods and chemical compounds.

Note: Specific claim language and detailed technical disclosures were not available; this analysis is based on standard practices in patent interpretation and known patent landscape methodologies.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.